title: Effects of chromium on humoral and cell-mediated immune responses and host resistance to disease in a freshwater catfish, Saccobranchus fossilis (Bloch).
abstract: The effects of subtoxic levels of Cr on humoral and cell-mediated immune responses, blood parameters, susceptibility to bacterial (Aeromonas hydrophila) infection, and macrophage activity in the freshwater air-breathing Asian catfish, Saccobranchus fossilis, during a 28-day exposure were examined by a static bioassay test procedure. At 0.1, 1.0, and 3.2 mg / liter Cr, dose-dependent Cr accumulation in kidney, liver, and spleen was observed at the end of the experiment. Chromium exposure caused a significant change in spleen to body weight ratio. Fish exposed to Cr concentrations had lower antibody titer values, reduced numbers of splenic and kidney plaque-forming cells, and higher counts of splenic lymphocytes but reduced counts of kidney cells when compared with the control group. At 0.1, 1.0, and 3.2 mg /liter Cr, dose-dependent decreases in red blood cell counts, hemoglobin content, and packed cell volume were observed. Differential leukocyte counts revealed that Cr exposure caused a significant decrease in large and small lymphocytes, whereas neutrophils and thrombocytes increased. Effects of Cr exposure to mitogen (Con A) on proliferation of splenic and pronephric lymphocytes suggests a decrease in mitogenic response. The eye-allograft rejection time, as a parameter of cell-mediated immunity, was statistically increased at 1.0 and 3.2 mg/liter Cr. Fish exposed to Cr for 28 days exhibited higher susceptibility to A. hydrophila infection than control fish. The results suggest that Cr exposure reduced the resistance of catfish to bacterial infections. The phagocytic activity of splenic and pronephros macrophages was examined in vitro and found to be significantly decreased.
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002397:Catfishes / Q000276:immunology*; D002857:Chromium / Q000493:pharmacokinetics / Q000633:toxicity*; D003208:Concanavalin A / Q000494:pharmacology; D005123:Eye / Q000637:transplantation; D006386:Hemagglutination Tests; D007111:Immunity, Cellular / Q000187:drug effects; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology; D007958:Leukocyte Count / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects / Q000276:immunology